Although gastrointestinal adverse events (AEs), such as nausea, are more common in the 3 mg treatment group, other AEs such as hypoglycemic episodes and pancreatitis did not show dose dependency
It also arrives at an unusual moment for Medicare, which is about to cover certain weight-loss drugs for the first time in its history
Many health plans arent required to cover weight-loss medications, and even when semaglutide is covered, people may still face prior authorization requirements, step therapy rules, high deductibles, or coinsurance
Some compounds may even enhance the absorption or metabolism of others, further increasing the bioavailability of these powerful antioxidants
doi: 10.1056/NEJMoa2107519 48 LudvikBGiorginoFJdarEFriasJPFernndez LandLBrownKet al